Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma. - Wikidata - wikimedia - TriplyDB

Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.

Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.

http://www.wikidata.org/entity/Q34976425

about

Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma Downregulation of NAD(P)H:quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells.Clinical implications of high NQO1 expression in breast cancers Predictors for the development of cholangiocarcinoma and hepatocellular carcinoma: in search for the most accurate biomarker.Correlation of NQO1 and Nrf2 in Female Genital Tract Cancer and Their Precancerous Lesions (Cervix, Endometrium and Ovary).Adjuvant treatment in biliary tract cancer: to treat or not to treat?The expression and clinicopathological role of CDX2 in intrahepatic cholangiocarcinoma.

P2860

Q26852680-C33286CF-26BA-4CA7-BC56-FB56619DA1DF Q33751337-1105A1DB-971C-4E21-A2AD-E666FA5227AF Q37621051-2AF9DB3D-0896-4C5D-BD89-169E85281048 Q40623765-1EE17C56-DBAB-4DE6-A74A-E42A5F4B2F3A Q42009367-63EE0A16-F3E7-4614-AE90-CC6FB2B64678 Q43193059-66C4E0D5-45E1-48FF-BF68-9FEBD076AB67 Q55312215-E359AE45-A218-4238-9E08-B85CA04DC726

P2860

Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.

http://www.wikidata.org/entity/Q34976425

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.

@ast

Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.

@en

Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.

@nl

type

label

Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.

@ast

Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.

@en

Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.

@nl

prefLabel

Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.

@ast

Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.

@en

Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.

@nl

P1433

Q34976425-83C3A477-DEC5-4BC0-B179-5FA2889F4FDC

P1476

Q34976425-38F91D0A-35A6-4AA9-8B14-0B86AD1524E4

P2093

Q34976425-49593E7B-867E-4B0E-B5C0-B668519FB987

Q34976425-54AD83D0-37D0-4922-8332-75298AF4938B

Q34976425-B9558C89-553A-4C1B-A950-EA96F1BACD30

Q34976425-BB174FD8-53D8-4032-AE04-7FCC709C9485

Q34976425-BC8E5B08-B8BA-4C28-96D4-CBD78F87D7DE

Q34976425-CDE0C701-B000-4C4B-9F6E-E2F6F739D0FB

Q34976425-F2C7A406-C812-4817-A14D-BEFD5CA5C8A1

Q34976425-FE75862C-3186-45E6-8BE8-C7CA403FEDDE

P2860

Q34976425-011C0AEF-4843-4C6B-ABAA-8A2B02C83286

Q34976425-0D4F7904-8504-425D-8119-40435E18C9F8

Q34976425-34FF0D03-6289-4D63-97D7-8BCC447D9262

Q34976425-4376B0F9-6515-4713-B431-865FD246AB9F

Q34976425-480154E7-611E-4B1C-A180-25F599F9EA5A

Q34976425-488B80D8-0B3A-4614-8F55-5DCCC4CF3482

Q34976425-6E62D7A3-0A9E-474F-A4AC-4E2439335F8D

Q34976425-852D299A-DB45-4422-B5A4-17B0178A1F8D

Q34976425-8D0EBB1C-1922-4AC9-A6D4-52973D18CD55

Q34976425-A85DD865-D261-411F-8426-AB213376D403

P304

Q34976425-2E4E3106-5B14-4831-9C5D-AB2CCACD4BD9

P31

Q34976425-2C7059EB-FA64-4B2B-8AE8-B2860670159A

P433

Q34976425-C6DA868B-68A8-4B33-910B-0728775767D6

P478

Q34976425-D833FBA1-E9B1-42CE-A236-2EB83BEEE631

P577

Q34976425-1966AAB1-A4DE-4FCD-B213-1548789CC191

P698

Q34976425-275A6F21-6B04-4962-BFDB-FB68BCFD800B

P921

Q34976425-7B9F3425-7107-4E48-A9E4-CD4D80177D92

P932

Q34976425-720186D2-B2FB-4A15-A724-4E7402358CBA

P1433

International Journal of Clinical and Experimental Pathology

P1476

Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma

@en

P2093

Jun Sakata

http://www.w3.org/2001/XMLSchema#string

Katsuyoshi Hatakeyama

http://www.w3.org/2001/XMLSchema#string

Masaaki Takamura

http://www.w3.org/2001/XMLSchema#string

Pavel V Korita

http://www.w3.org/2001/XMLSchema#string

Toshifumi Wakai

http://www.w3.org/2001/XMLSchema#string

Yasunobu Matsuda

http://www.w3.org/2001/XMLSchema#string

Yoichi Ajioka

http://www.w3.org/2001/XMLSchema#string

Yoshio Shirai

http://www.w3.org/2001/XMLSchema#string

P2860

Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene

Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells

Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1.

Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.

NQO1 stabilizes p53 through a distinct pathway.

Regulation of genes encoding NAD(P)H:quinone oxidoreductases.

Breast cancer: role of polymorphisms in biotransformation enzymes.

Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1

Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy.

Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy.

P304

363-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21577322

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

3093061

http://www.w3.org/2001/XMLSchema#string